Eevia Health Plc ("Eevia" or "The Company") is planning to divest business assets related to Retinari™, a prospective eye health compound with auspicious pre-clinical results for the support of eye health. The aim is to protect the value of market opportunities that Eevia cannot commercialize with its current resource base. …
